Sterling Capital Management’s scPharmaceuticals SCPH Stock Holding History

Sterling Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-96	Closed	-$544	–	3268
2025 Q3	$544	Buy	96 +4	+4%	+$20	﹤0.01%	3148
2025 Q2	$351	Buy	92 +63	+217%	+$196	﹤0.01%	3192
2025 Q1	$76	Hold	29	–	–	﹤0.01%	3161
2024 Q4	$103	Hold	29	–	–	﹤0.01%	3177
2024 Q3	$132	Buy	+29	New	+$140	﹤0.01%	3158

Sterling Capital Management's SCPH Position: Q4 2025 in Review

Sterling Capital Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 96 shares — an estimated $544 sold.

Sterling Capital Management first reported a position in SCPH in Q3 2024 and held it in 5 quarters. The position peaked at $544 in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Sterling Capital Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Sterling Capital Management sold 96 scPharmaceuticals shares in Q4 2025, an estimated $544.
Sterling Capital Management first reported a position in scPharmaceuticals in Q3 2024 and held it in 5 quarters.
Sterling Capital Management's scPharmaceuticals position peaked at $544 in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Sterling Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.